NCT03872531
Achondroplasia
The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.
Observational study looking at the burden of illness in achondroplasia subjects aged 3 and above. The study will include a 3 year review of historical clinical data as well as a single point collection of questionnaire data to look at the impact on the following in individuals with achondroplasia versus a normative population:
* Quality of life
* Clinical burden
* Healthcare resource use
* Socio-economic burden
* Psychosocial burden
Up to 175 subjects will be enrolled in sites in Argentina, Colombia and Brazil.
All
3 Years to 100 Years
No
Observational
173
2019-03-31
2021-04-05
Buenos Aires, , Argentina
Rio de Janeiro, , Brazil
São Paulo, , Brazil
Bogotá, , Colombia
1. Individual with a documented diagnosis of achondroplasia based on:
1. Genetic confirmation of achondroplasia and/or
2. Clinical diagnosis of achondroplasia (clinical examination and/or radiological assessment)
2. ≥ three years of age at the time of enrollment
3. Has the cognitive and linguistic capacities necessary to complete questionnaires in the language of his/her country (and/or parents/legally acceptable representatives, as applicable)
4. Agrees to participate in the study and has read, understood, completed and signed:
1. Informed Consent Form (ICF) – for adult subjects
2. Informed Assent Form (IAF) – for minor subjects, accompanied by a parental ICF completed by their parents/legally acceptable representatives. The age at which the minor subjects sign the IAF will be subject to local requirements.
5. Has medical records available for the three years prior to the date of enrollment.
1. Currently participating, or participated in the last six months, in
1. a clinical trial of a medicinal product or medical device or
2. other non-clinical or low interventional studies
2. Currently participating or has participated in any BioMarin study at any time
By completing this form and clicking the send button, you understand and hereby consent to storage of your personal information, including within the United States and Europe, which will be accessible by BioMarin for purposes such as responding to your request, quality control, fulfilling compliance obligations, and assisting with products, services, or clinical trials. Depending on where you live, you may have the right to request access to, removal, or correction of your personal information held by BioMarin. You may submit your request via the contact information and/or webform located within the full BioMarin Privacy Policy.
*required fields
"*" indicates required fields